![](/img/cover-not-exists.png)
Gemtuzumab ozogamicin (Mylotarg) has therapeutic activity against CD33+ acute lymphoblastic leukaemias in vitro and in vivo
J. Golay, N. Di Gaetano, D. Amico, E. Cittera, A. M. Barbui, R. Giavazzi, A. Biondi, A. Rambaldi, M. IntronaVolume:
128
Year:
2005
Language:
english
Pages:
8
DOI:
10.1111/j.1365-2141.2004.05322.x
File:
PDF, 257 KB
english, 2005